A solution guide for evaluating AI that identifies patient cohorts for quality programs, care gaps, outreach, population health, and research-adjacent workflows.
Summary
Cohort identification AI should make inclusion logic, data provenance, exclusions, and outreach responsibilities transparent.
Workflow checkpoints
Cohort logic and data sources
AI can help combine diagnoses, labs, medications, utilization, notes, and claims into target cohorts.
- Document inclusion, exclusion, and refresh logic.
- Track data provenance across EHR, claims, and registry sources.
- Validate cohort output against trusted samples.
Care gap and outreach workflow
A cohort is only useful when it connects to action, owner assignment, patient communication, and outcome measurement.
- Route cohorts to care teams, outreach tools, or quality programs.
- Review bias, missing data, and subgroup performance.
- Measure completion, exceptions, and patient outcomes.
Evaluation criteria
- Cohort definition transparency, data source coverage, refresh cadence, and validation method.
- Integration with EHR, registry, claims, care gap, outreach, and population health workflows.
- Bias review, patient matching, consent, audit logs, and reviewer accountability.
Population health and data infrastructure
Tools that normalize clinical data, identify cohorts, and support care gap programs.
Related tools: innovaccer, health-gorilla, redox
Care gap and engagement workflows
Tools that connect identified cohorts to patient outreach and follow-up work.
Related tools: luma-health, phreesia, notable-health
Compliance considerations
- Review PHI use, consent, BAA terms, data provenance, access controls, retention, and audit logs.
- Validate cohort logic for missing data, patient matching errors, bias, and unintended exclusions.
- Define clinical or operational review before outreach, registry submission, or program enrollment.
Medical and editorial note
This solution guide is for cohort identification technology procurement research and is not medical, research, population health, legal, privacy, or compliance advice.
Sources and review notes
These links support workflow-level research and do not establish the regulatory status, clinical safety, diagnostic performance, or suitability of any product.
HL7 FHIR distinguishes a Group that describes possible members by characteristics from an actual Group that enumerates identified members, and supports inclusion or exclusion characteristics and membership periods. CMS quality-measure resources separately define population criteria such as initial populations, denominators, numerators and exclusions with explicit data constraints, value sets and timing. ONC's Health IT Playbook places population identification within a broader workflow of registries, panel management, care management and action. NIST AI RMF is voluntary and use-case agnostic but provides a governance, mapping, measurement and management framework for AI risks, including validity, reliability, transparency, privacy and harmful bias. These sources do not define one correct cohort for every care, quality, operations, public-health or research-adjacent purpose and do not validate a vendor model. Buyers should define the cohort purpose, accountable owner, authoritative policy, protocol or measure version, inclusion and exclusion logic, index and lookback dates, enrollment and observation windows, refresh cadence, source systems, patient-matching method, terminology versions, missing and conflicting-data behavior, consent and permitted use, downstream action, capacity and stop criteria before model selection. Validation should use longitudinal adjudicated cases and separately report eligibility-rule execution, patient matching, data availability and any model contribution; include precision, recall, false inclusion and exclusion, calibration where relevant, subgroup and site performance, uncertainty, reviewer agreement and change sensitivity; and test stale claims, incomplete encounters, merged identities, corrected results, outside care, deaths, moves, enrollment changes, sparse histories and source outages. Every candidate should retain the cohort and logic version, source facts and dates, provenance, reason, uncertainty, reviewer decision, correction and downstream disposition. AI may retrieve evidence, normalize data or prioritize review, but it should not fabricate missing facts, convert area-level or proxy data into individual facts, silently alter criteria, or autonomously diagnose, determine benefits or medical necessity, enroll or exclude research participants, suppress services or initiate consequential outreach. Quality, clinical, research, privacy, legal, compliance, data and equity reviewers should approve the intended use, validation, monitoring, incident response, rollback and revalidation after source, rule, model or population changes.
